The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

WellPoint Reports Fourth Quarter and Full Year 2011 Results and Provides 2012 Outlook

<ul> <li class='bwlistitemmargb'> <b>Fourth quarter 2011 net income was $0.96 per share, including net investment losses of $0.03 per share</b> </li> <li class='bwlistitemmargb'> <b>Full year 2011 net income was $7.25 per share, including net investment gains of $0.25 per share</b> </li> <li class='bwlistitemmargb'> <b>Medical enrollment increased by 928,000 members in 2011 and totaled 34.3 million members as of December 31, 2011</b> </li> <li class='bwlistitemmargb'> <b>Selling, general and administrative expense declined by $297 million, or 3.4 percent, in 2011</b> </li> <li class='bwlistitemmargb'> <b>Full year 2012 net income expected to be at least $7.60 per share</b> </li> <li class='bwlistitemmargb'> <b>Board of Directors increases dividend by 15 percent and declares first quarter 2012 dividend of $0.2875 per share</b> </li> </ul>

Wednesday, January 25, 2012

WellPoint Reports Fourth Quarter and Full Year 2011 Results and Provides 2012 Outlook06:00 EST Wednesday, January 25, 2012 INDIANAPOLIS (Business Wire) -- WellPoint, Inc. (NYSE: WLP) today announced that fourth quarter 2011 net income was $335.3 million, or $0.96 per share, including net investment losses of $11.7 million after-tax, or $0.03 per share. Net income in the fourth quarter of 2010 was $548.8 million, or $1.40 per share, including net investment gains of $24.1 million after-tax, or approximately $0.07 per share. Excluding the net investment gains and losses in each period, adjusted net income was $0.99 per share in the fourth quarter of 2011, compared with adjusted net income of $1.33 per share in the prior year quarter (refer to GAAP reconciliation table for a reconciliation to the most directly comparable measure calculated in accordance with U.S. generally accepted accounting principles, or “GAAP”). For the full year of 2011, net income was $2.6 billion, or $7.25 per share, and included net investment gains of $92.2 million after-tax, or $0.25 per share. Excluding the net investment gains, full year 2011 adjusted net income was $7.00 per share (refer to GAAP reconciliation table). For the full year of 2010, net income was approximately $2.9 billion, or $6.94 per share, and included net investment gains of $100.2 million after-tax, or approximately $0.23 per share, partially offset by an intangible asset impairment charge of $13.7 million after-tax, or $0.03 per share. Excluding these items, full year 2010 adjusted net income was $6.74 per share (refer to GAAP reconciliation table). “Our fourth quarter results were at the high end of our guidance range and concluded a successful 2011. During the year, we added 928,000 new medical members and achieved financial results that were in-line or better than we expected in most of our businesses. We also created a more efficient organization and executed on a number of strategic initiatives as we prepare to capitalize on the important future growth opportunities we see in the marketplace,” said Angela F. Braly, chair, president and chief executive officer. “We have the right strategies in place to continue improving the lives of the people we serve and the health of our communities. We are looking forward to delivering even more health care value in 2012 and continue to expect long-term growth and success.” “In 2012, we expect earnings per share of at least $7.60, which represents an increase of greater than 8.5 percent over adjusted EPS of $7.00 in 2011. We also expect to generate at least $2.9 billion of operating cash flow and will continue using our capital to reinvest in our businesses and enhance value for our customers and shareholders,” said Wayne S. DeVeydt, executive vice president and chief financial officer. “I am also pleased to announce that, yesterday, the Board of Directors increased our dividend by 15 percent. The Board's continued support of our share repurchase and dividend programs reflects their commitment to and confidence in our strategy and execution.” CONSOLIDATED HIGHLIGHTSMembership: Medical enrollment totaled approximately 34.3 million members at December 31, 2011, an increase of 928,000 members, or 2.8 percent, from 33.3 million at December 31, 2010. The increase was driven by growth of 596,000 members, or 5.1 percent, in the National business. Enrollment in the Senior business increased by 212,000 members, or 16.8 percent, including 57,000 members from the acquisition of CareMore Health Group (“CareMore”) in the third quarter of 2011. The Company also grew organically by 111,000 and 72,000 members, respectively, in the State Sponsored and Federal Employee Program (“FEP”) businesses. Local Group membership was essentially flat, while Individual membership declined by 59,000. Operating Revenue:Operating revenue totaled approximately $15.2 billion in the fourth quarter of 2011, an increase of $785.2 million, or 5.5 percent, from $14.4 billion in the fourth quarter of 2010. Approximately $230 million of the increase related to the CareMore acquisition. The remaining increase was driven by premium increases designed to cover overall cost trends and membership growth in the Senior business, partially offset by a decline in fully insured Commercial membership. Benefit Expense Ratio:The benefit expense ratio was 87.6 percent in the fourth quarter of 2011, which was in-line with the Company's expectation and represented an increase of 310 basis points from 84.5 percent in the fourth quarter of 2010. The increase was driven by the Consumer segment and included adverse selection in certain Medicare Advantage products. The benefit expense ratio also increased in the Local Group business as the Company complied with the Patient Protection and Affordable Care Act, and as a result of changes in reserves. The Company recognized an estimated $105 million of higher than anticipated pre-tax income during the fourth quarter of 2010, due to a reduction in the targeted margin for adverse deviation and higher than anticipated prior period reserve development. Medical Cost Trends: Trends represent Local Group fully insured business. For the full year of 2011, the Company estimates that underlying medical cost trend was approximately 7 percent. Unit cost increases, including an increase in the acuity of services, continue to be the primary driver of overall medical cost trend. Days in Claims Payable:Days in Claims Payable (“DCP”) as of December 31, 2011, was 40.6 days, a decrease of 1.0 day from 41.6 days at September 30, 2011. This reflected the seasonal increase in benefit expense that occurs in the fourth quarter of a calendar year, partially offset by an increase in medical claims payable. DCP was 1.3 days higher than the 39.3 days reported as of December 31, 2010, and 0.9 days higher than year-end 2010 when excluding the impact of the CareMore acquisition. SG&A Expense Ratio: The SG&A expense ratio was 14.7 percent in the fourth quarter of 2011, a decrease of 160 basis points from 16.3 percent in the fourth quarter of 2010. This reflected operating revenue growth of 5.5 percent, combined with a $112.2 million, or 4.8 percent, reduction in SG&A expense. The decrease in SG&A expense reflected administrative cost reductions associated with the Company's continuous improvement initiatives and lower incentive compensation, partially offset by approximately $50 million of restructuring expenses and investments in branding in the fourth quarter of 2011 and approximately $45 million of CareMore expenses. Operating Cash Flow: Operating cash flow was $57.9 million in the fourth quarter of 2011 due to the timing of the October 2011 payment from the Centers for Medicare & Medicaid Services, which was received in the third quarter and totaled $596.5 million. Including this payment in the fourth quarter, adjusted operating cash flow was $654.4 million, or nearly 2.0 times net income (refer to GAAP reconciliation table for a reconciliation to the most directly comparable measure calculated in accordance with GAAP). For the full year of 2011, operating cash flow totaled approximately $3.4 billion, or 1.3 times net income. For the full year of 2010, operating cash flow was $1.4 billion and included $1.2 billion of tax payments related to the 2009 sale of the NextRx pharmacy benefit management subsidiaries. Excluding the NextRx tax payments, adjusted operating cash flow was $2.6 billion in 2010, or 0.9 times net income (refer to GAAP Reconciliation). Share Repurchase Program: During the fourth quarter of 2011, the Company repurchased 10.3 million shares of its common stock for $685.6 million. For full year of 2011, the Company repurchased 44.5 million shares of common stock, or 11.8 percent of the shares outstanding at December 31, 2010, for $3.0 billion. As of December 31, 2011, the Company's remaining Board-approved share repurchase authorization totaled $4.3 billion. Cash Dividend: During the fourth quarter of 2011, the Company paid a quarterly dividend of $0.25 per share, representing a distribution of cash totaling $85.7 million. On January 24, 2012, the Board of Directors increased the Company's dividend by 15 percent and declared a quarterly dividend to shareholders for the first quarter of 2012 of $0.2875 per share. The first quarter dividend is payable on March 23, 2012, to shareholders of record at the close of business on March 9, 2012. Investment Portfolio & Capital Position: During the fourth quarter of 2011, the Company recorded net investment losses of $18.0 million pre-tax, consisting of other than temporary impairments totaling $59.6 million, partially offset by net realized gains from the sale of securities totaling $41.6 million. In the fourth quarter of 2010, the Company recorded net investment gains of $37.2 million pre-tax, consisting of net realized gains from the sale of securities totaling $47.6 million, partially offset by other-than-temporary impairments totaling $10.4 million. As of December 31, 2011, the Company's net unrealized gain position in the investment portfolio was $936.4 million, consisting of net unrealized gains on fixed maturity and equity securities totaling $685.5 million and $250.9 million, respectively. As of December 31, 2011, cash and investments at the parent company totaled $2.7 billion. REPORTABLE SEGMENTS WellPoint, Inc. has the following reportable segments: Commercial Business, which includes the Local Group, National, UniCare and Specialty Products lines of business; Consumer Business, which includes the Individual, Senior and State Sponsored lines of business; and Other, which includes Comprehensive Health Solutions, FEP business, National Government Services, inter-segment sales and expense eliminations, and corporate expenses not allocated to the other reportable segments. Operating revenue and operating gain are the key measures used by management to evaluate performance in each segment.   WellPoint, Inc.Reportable Segment Highlights (Unaudited)               (In millions) Three Months Ended December 31 Year Ended December 31 2011 2010 Change 2011 2010 Change Operating Revenue Commercial Business $ 8,629.2 $ 8,531.9 1.1 % $ 34,498.0 $ 34,559.3 (0.2 %) Consumer Business 4,620.7 4,048.4 14.1 % 17,784.9 16,092.6 10.5 % Other   1,925.6     1,810.0   6.4 %   7,582.3     7,088.6   7.0 % Total Operating Revenue 15,175.5 14,390.3 5.5 % 59,865.2 57,740.5 3.7 %   Operating Gain / (Loss) Commercial Business $ 506.7 $ 600.7 (15.6 %) $ 3,090.5 $ 3,085.7 0.2 % Consumer Business (4.6 ) 112.0 (104.1 %) 623.1 1,000.6 (37.7 %) Other   10.4     (19.6 ) NM (1)   68.5     (8.8 ) NM (1) Total Operating Gain 512.5 693.1 (26.1 %) 3,782.1 4,077.5 (7.2 %)   Operating Margin Commercial Business 5.9 % 7.0 % (110) bp 9.0 % 8.9 % 10 bp Consumer Business -0.1 % 2.8 % (290) bp 3.5 % 6.2 % (270) bp Total Operating Margin 3.4 % 4.8 % (140) bp 6.3 % 7.1 % (80) bp   (1) "NM" = not meaningful     Commercial Business: Operating gain for the Commercial Business segment was $506.7 million in the fourth quarter of 2011, a decrease of $94.0 million, or 15.6 percent, from $600.7 million in the fourth quarter of 2010. The decline was driven primarily by changes in reserves, as an estimated $65 million of operating gain was recognized in the fourth quarter of 2010 due to the reduction in the targeted margin for adverse deviation and higher than anticipated prior period reserve development. The comparison to the prior year quarter also reflects the impact of minimum medical loss ratio requirements in 2011 and the lower than anticipated medical costs the Company experienced in the Local Group business at the end of 2010. Consumer Business: The Company experienced an operating loss of $4.6 million in the Consumer segment during the fourth quarter of 2011, compared with an operating gain of $112.0 million in the prior year quarter. The decline was driven by higher medical costs in the Senior business and changes in reserves. An estimated $40 million of operating gain was recognized during the fourth quarter of 2010 due to the reduction in the targeted margin for adverse deviation and higher than anticipated prior period reserve development. The Company has refined its Medicare Advantage products and pricing for 2012. Other: Operating gain in the Other segment was $10.4 million in the fourth quarter of 2011, compared with an operating loss of $19.6 million in the fourth quarter of 2010. This reflected lower corporate expenses and increased FEP business in the current year quarter. OUTLOOKFull Year 2012: Net income is expected to be at least $7.60 per share. Year-end medical enrollment is expected to be approximately 33.7 million members, consisting of approximately 20.2 million self-funded members and approximately 13.5 million fully insured members. Operating revenue is expected to total approximately $62.1 billion. The benefit expense ratio is expected to be approximately 85.3 percent. The SG&A expense ratio is expected to be approximately 13.6 percent. Operating cash flowis expected to be at least $2.9 billion. Basis of Presentation 1.   Operating gain is defined as operating revenue less benefit expense, selling expense and general and administrative expense. Operating gain is used to analyze profit or loss on a segment basis. Consolidated operating gain is a non-GAAP measure.   2. Operating margin is defined as operating gain divided by operating revenue. Consolidated operating margin is a non-GAAP measure.   3. Certain prior period amounts have been reclassified to conform to the current period presentation (see Reclassified Consolidated Statement of Income).   Conference Call and Webcast Management will host a conference call and webcast today at 8:00 a.m. Eastern Standard Time (“EST”) to discuss its fourth quarter earnings results and 2012 outlook. The conference call should be accessed at least 15 minutes prior to the start of the call with the following numbers:         888-423-3268 (Domestic)         800-475-6701 (Domestic Replay) 651-291-5254 (International) 320-365-3844 (International Replay) An access code is not required for today's conference call. The access code for the replay is 228586. The replay will be available from 11 a.m. EST today until the end of the day on February 8, 2012. The call will also be available through a live webcast at www.wellpoint.com. A webcast replay will be available following the call. About WellPoint, Inc. WellPoint works to simplify the connection between Health, Care and Value. We help to improve the health of our members and our communities, and provide greater value to our customers and shareholders. WellPoint is one of the nation's largest health benefits companies, with 34 million members in its affiliated health plans, and a total of more than 65 million individuals served through its subsidiaries. As an independent licensee of the Blue Cross and Blue Shield Association, WellPoint serves members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as the Blue Cross Blue Shield licensee in 10 New York City metropolitan and surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), and Wisconsin. In a majority of these service areas, WellPoint's plans do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross Blue Shield, or Empire Blue Cross (in the New York service areas). WellPoint also serves customers throughout the country as UniCare and in certain California, Arizona and Nevada markets through our recently acquired CareMore Health Group, Inc. subsidiary. Additional information about WellPoint is available at www.wellpoint.com.     WellPoint, Inc.Membership Summary (Unaudited and in Thousands)             Change from December 31, December 31, September 30, December 31, September 30, Medical Membership 2011 2010 2011 2010 2011 Customer Type Local Group 15,212 15,216 15,296 (0.0 %) (0.5 %)   National Accounts 7,401 7,029 7,435 5.3 % (0.5 %) BlueCard 4,935 4,711 4,961 4.8 % (0.5 %) Total National 12,336 11,740 12,396 5.1 % (0.5 %)   Individual 1,846 1,905 1,855 (3.1 %) (0.5 %) Senior 1,471 1,259 1,442 16.8 % 2.0 % State Sponsored 1,867 1,756 1,849 6.3 % 1.0 % FEP 1,519 1,447 1,517 5.0 % 0.1 % Total Medical Membership 34,25133,32334,355 2.8 % (0.3 %)   Funding Arrangement Self-Funded 20,506 19,590 20,570 4.7 % (0.3 %) Fully-Insured 13,745 13,733 13,785 0.1 % (0.3 %) Total Medical Membership 34,25133,32334,355 2.8 % (0.3 %)   Reportable Segment Commercial 27,548 26,959 27,692 2.2 % (0.5 %) Consumer 5,184 4,917 5,146 5.4 % 0.7 % Other 1,519 1,447 1,517 5.0 % 0.1 % Total Medical Membership 34,25133,32334,355 2.8 % (0.3 %)   Other Membership Behavioral Health Membership 25,135 23,963 25,203 4.9 % (0.3 %) Life and Disability Membership 5,012 5,201 5,014 (3.6 %) (0.0 %) Dental Membership 4,046 4,007 4,079 1.0 % (0.8 %) Managed Dental Membership 4,162 4,272 4,318 (2.6 %) (3.6 %) Vision Membership 3,783 3,508 3,765 7.8 % 0.5 % Medicare Part D Membership 1,242 1,248 1,232 (0.5 %) 0.8 %       WellPoint, Inc.Consolidated Statements of Income (Unaudited)         Three Months Ended (In millions, except per share data) December 31 2011 2010 Change Revenues Premiums $ 14,190.3 $ 13,439.9 5.6 % Administrative fees 971.8 942.7 3.1 % Other revenue   13.4     7.7   74.0 % Total operating revenue 15,175.5 14,390.3 5.5 %   Net investment income 160.2 194.5 (17.6 %) Net realized gains on investments 41.6 47.6 (12.6 %)   Other-than-temporary impairment losses on investments: Total other-than-temporary impairment losses on investments (70.0 ) (17.6 ) (297.7 %) Portion of other-than-temporary impairment losses recognized in other comprehensive income   10.4     7.2   44.4 % Net other-than-temporary impairment losses recognized in income   (59.6 )   (10.4 ) (473.1 %)   Total revenues 15,317.7 14,622.0 4.8 %   Expenses Benefit expense 12,434.6 11,356.6 9.5 % Selling, general and administrative expense Selling expense 411.2 404.1 1.8 % General and administrative expense   1,817.2     1,936.5   (6.2 %) Total selling, general and administrative expense 2,228.4 2,340.6 (4.8 %) Interest expense 112.6 113.0 (0.4 %) Amortization of other intangible assets   63.9     59.7   7.0 % Total expenses 14,839.5 13,869.9 7.0 %   Income before income taxes 478.2 752.1 (36.4 %)   Income tax expense   142.9     203.3   (29.7 %)   Net income $ 335.3   $ 548.8   (38.9 %)   Net income per diluted share $ 0.96   $ 1.40   (31.4 %)   Diluted shares 349.6 393.4 (11.1 %)   Benefit expense as a percentage of premiums 87.6 % 84.5 % 310 bp Selling, general and administrative expense as a percentage of total operating revenue 14.7 % 16.3 % (160) bp Income before income tax expense as a percentage of total revenues 3.1 % 5.1 % (200) bp       WellPoint, Inc.Consolidated Statements of Income (Unaudited)         Year Ended (In millions, except per share data) December 31 2011 2010 Change Revenues Premiums $ 55,969.6 $ 53,973.6 3.7 % Administrative fees 3,854.6 3,730.4 3.3 % Other revenue   41.0     36.5   12.3 % Total operating revenue 59,865.2 57,740.5 3.7 %   Net investment income 703.7 803.3 (12.4 %) Net realized gains on investments 235.1 194.1 21.1 %   Other-than-temporary impairment losses on investments: Total other-than-temporary impairment losses on investments (114.7 ) (70.8 ) (62.0 %) Portion of other-than-temporary impairment losses recognized in other comprehensive income   21.4     31.4   (31.8 %) Net other-than-temporary impairment losses recognized in income   (93.3 )   (39.4 ) (136.8 %)   Total revenues 60,710.7 58,698.5 3.4 %   Expenses Benefit expense 47,647.5 44,930.4 6.0 % Selling, general and administrative expense Selling expense 1,616.8 1,610.3 0.4 % General and administrative expense   6,818.8     7,122.3   (4.3 %) Total selling, general and administrative expense 8,435.6 8,732.6 (3.4 %) Interest expense 430.3 418.9 2.7 % Amortization of other intangible assets 239.4 241.7 (1.0 %) Impairment of other intangible assets   –     21.1   (100.0 %) Total expenses 56,752.8 54,344.7 4.4 %   Income before income taxes 3,957.9 4,353.8 (9.1 %)   Income tax expense   1,311.2     1,466.7   (10.6 %)   Net income $ 2,646.7   $ 2,887.1   (8.3 %)   Net income per diluted share $ 7.25   $ 6.94   4.5 %   Diluted shares 365.1 415.8 (12.2 %)   Benefit expense as a percentage of premiums 85.1 % 83.2 % 190 bp Selling, general and administrative expense as a percentage of total operating revenue 14.1 % 15.1 % (100) bp Income before income tax expense as a percentage of total revenues 6.5 % 7.4 % (90) bp       WellPoint, Inc.Consolidated Balance Sheets   (In millions)   December 31,2011   December 31,2010 (Unaudited) Assets Current assets: Cash and cash equivalents $ 2,201.6 $ 1,788.8 Investments available-for-sale, at fair value: Fixed maturity securities 15,913.1 16,069.5 Equity securities 1,188.1 1,236.2 Other invested assets, current 14.8 21.1 Accrued investment income 172.0 177.4 Premium and self-funded receivables 3,402.9 3,041.6 Other receivables 943.9 878.6 Income taxes receivable 105.8 32.3 Securities lending collateral 871.4 900.3 Deferred tax assets, net 424.8 460.9 Other current assets   1,859.0   1,534.1 Total current assets 27,097.4 26,140.8   Long-term investments available-for-sale, at fair value: Fixed maturity securities 246.8 221.8 Equity securities 28.8 33.4 Other invested assets, long-term 1,003.7 865.4 Property and equipment, net 1,418.1 1,155.5 Goodwill 13,858.7 13,264.9 Other intangible assets 7,931.7 7,996.8 Other noncurrent assets   433.6   488.3 Total assets $ 52,018.8 $ 50,166.9 Liabilities and shareholders' equityLiabilities Current liabilities: Policy liabilities: Medical claims payable $ 5,489.0 $ 4,852.4 Reserves for future policy benefits 55.1 56.4 Other policyholder liabilities   2,278.2   1,909.1 Total policy liabilities 7,822.3 6,817.9 Unearned income 926.5 891.4 Accounts payable and accrued expenses 3,124.1 2,942.2 Security trades pending payable 51.7 33.3 Securities lending payable 872.5 901.5 Short-term borrowings 100.0 100.0 Current portion of long-term debt 1,274.5 705.9 Other current liabilities   1,654.1   1,617.3 Total current liabilities 15,825.7 14,009.5   Long-term debt, less current portion 8,420.9 8,147.8 Reserves for future policy benefits, noncurrent 730.7 646.7 Deferred tax liability, net 2,724.0 2,586.9 Other noncurrent liabilities   1,029.3   963.4 Total liabilities 28,730.6 26,354.3 Shareholders' equity Common stock 3.4 3.8 Additional paid-in capital 11,679.2 12,862.6 Retained earnings 11,490.7 10,721.6 Accumulated other comprehensive income   114.9   224.6 Total shareholders' equity   23,288.2   23,812.6 Total liabilities and shareholders' equity $ 52,018.8 $ 50,166.9       WellPoint, Inc.Consolidated Statements of Cash Flows (Unaudited)     Year Ended December 31 (In millions) 2011   2010   Operating activities Net income $ 2,646.7 $ 2,887.1 Adjustments to reconcile net income to net cash provided by operating activities: Net realized gains on investments (235.1 ) (194.1 ) Net other-than-temporary impairment losses recognized in income 93.3 39.4 Loss on disposal of assets 3.3 1.9 Deferred income taxes 74.3 101.8 Amortization, net of accretion 541.5 497.7 Depreciation expense 95.7 103.1 Impairment of other intangible assets – 21.1 Impairment of property and equipment – 95.3 Share-based compensation 134.8 136.0 Excess tax benefits from share-based compensation (42.2 ) (28.1 ) Changes in operating assets and liabilities, net of effect of business combinations: Receivables, net (401.8 ) 109.7 Other invested assets (8.9 ) 5.1 Other assets (259.2 ) (320.1 ) Policy liabilities 978.0 (330.7 ) Unearned income 35.1 (158.6 ) Accounts payable and accrued expenses (208.7 ) (58.2 ) Other liabilities (13.6 ) (208.4 ) Income taxes (44.6 ) (1,239.8 ) Other, net   (14.2 )   (43.5 ) Net cash provided by operating activities 3,374.4 1,416.7   Investing activities Purchases of fixed maturity securities (11,914.8 ) (10,567.2 ) Proceeds from sales and maturities of fixed maturity securities 12,337.5 10,536.8 Purchases of equity securities (355.6 ) (350.9 ) Proceeds from sales of equity securities 287.4 197.9 Purchases of other invested assets (207.9 ) (91.4 ) Proceeds from sales of other invested assets 29.4 34.5 Changes in securities lending collateral 28.9 (504.8 ) Purchases of subsidiaries, net of cash acquired (600.0 ) (0.3 ) Purchases of property and equipment (519.5 ) (451.4 ) Proceeds from sales of property and equipment 3.7 0.8 Other, net   (31.1 )   (75.5 ) Net cash used in investing activities (942.0 ) (1,271.5 )   Financing activities Net proceeds from (repayment of) commercial paper borrowings 463.6 (164.4 ) Net proceeds from short-term borrowings – 100.0 Proceeds from long-term borrowings 1,097.4 1,088.5 Repayment of long-term borrowings (705.1 ) (481.7 ) Changes in securities lending payable (29.0 ) 504.9 Changes in bank overdrafts 264.3 (28.0 ) Repurchase and retirement of common stock (3,039.8 ) (4,360.3 ) Cash dividends (357.8 ) – Proceeds from issuance of common stock under employee stock plans 245.0 143.6 Excess tax benefits from share-based compensation   42.2     28.1   Net cash used in financing activities   (2,019.2 )   (3,169.3 )   Effects of foreign currency exchange rate changes on cash and cash equivalents   (0.4 )   (3.2 )   Change in cash and cash equivalents 412.8 (3,027.3 ) Cash and cash equivalents at beginning of year   1,788.8     4,816.1   Cash and cash equivalents at end of year $ 2,201.6   $ 1,788.8         WellPoint, Inc.Reconciliation of Medical Claims Payable         Years Ended December 31 (In millions) 2011 2010 2009     Gross medical claims payable, beginning of year $ 4,852.4 $ 5,450.5 $ 6,184.7 Ceded medical claims payable, beginning of year   (32.9 )   (29.9 )   (60.3 ) Net medical claims payable, beginning of year 4,819.5 5,420.6 6,124.4   Business combinations and purchase adjustments 100.9 – 2.8   Net incurred medical claims: Current year 47,281.6 45,077.1 47,315.1 Prior years (redundancies) 1   (209.7 )   (718.0 )   (807.2 ) Total net incurred medical claims 47,071.9 44,359.1 46,507.9   Net payments attributable to: Current year medical claims 41,999.0 40,387.8 42,056.9 Prior years medical claims   4,520.7     4,572.4     5,157.6   Total net payments 46,519.7 44,960.2 47,214.5   Net medical claims payable, end of year 5,472.6 4,819.5 5,420.6 Ceded medical claims, end of year   16.4     32.9     29.9   Gross medical claims payable, end of year $ 5,489.0   $ 4,852.4   $ 5,450.5     Current year medical claims paid as a percent of current year net incurred medical claims 88.8 % 89.6 % 88.9 %   Prior year redundancies in the current year as a percent of prior year net medical claims payables less prior year redundancies in the current year 4.5 % 15.3 % 15.2 %   Prior year redundancies in the current year as a percent of prior year net incurred medical claims 0.5 % 1.5 % 1.7 %   (1) Negative amounts reported for net incurred medical claims related to prior years result from claims being settled for amounts less than originally estimated.       WellPoint, Inc.GAAP Reconciliation (Unaudited)         WellPoint, Inc. has referenced "Adjusted Net Income" and "Adjusted Net Income Per Share," non-GAAP financial measures, in this document. These non-GAAP financial measures are not intended to be alternatives to any measure calculated in accordance with GAAP. Rather, these non-GAAP financial measures are intended to aid investors when comparing WellPoint, Inc.'s financial results among periods. A reconciliation of these measures to the most directly comparable measures calculated in accordance with GAAP is presented below.         (In millions, except per share data) Three Months Ended December 31, 2011 December 31, 2010 Change   Net income $ 335.3 $ 548.8 (38.9 %) Add (net of tax): Net investment losses, net of $6.3 tax benefit $ 11.7 Subtract (net of tax): Net investment gains, net of $13.1 of tax expense   –     (24.1 ) Net adjustment items   11.7     (24.1 )   Adjusted net income $ 347.0   $ 524.7   (33.9 %)   Diluted shares 349.6 393.4 (11.1 %)   Net income per diluted share $ 0.96 $ 1.40 (31.4 %) Adjusted net income per diluted share $ 0.99 $ 1.33 (25.6 %)     Year Ended December 31, 2011 December 31, 2010 Change   Net income $ 2,646.7 $ 2,887.1 (8.3 %) Add (net of tax): Impairment of other intangible assets, net of $7.4 tax benefit – 13.7 Subtract (net of tax): Net investment gains, net of $49.6 and $54.5 of tax expense, respectively   (92.2 )   (100.2 ) Net adjustment items   (92.2 )   (86.5 )   Adjusted net income $ 2,554.5   $ 2,800.6   (8.8 %)   Diluted shares 365.1 415.8 (12.2 %)   Net income per diluted share $ 7.25 $ 6.94 4.5 % Adjusted net income per diluted share $ 7.00 $ 6.74 3.9 %       WellPoint, Inc.GAAP Reconciliation (Unaudited)       WellPoint, Inc. has referenced "Adjusted Operating Cash Flow" a non-GAAP measure, in this document. This non-GAAP measure is not intended to be an alternative to any measure calculated in accordance with GAAP. Rather, this non-GAAP measure is intended to aid investors when comparing WellPoint, Inc.'s financial results among periods. A reconciliation of this measure to the most directly comparable measure calculated in accordance with GAAP is presented below.         (In millions) Three Months Ended December 31, 2011 December 31, 2010   Operating cash flow $ 57.9 $ 587.0 Add: October 2011 CMS payment   596.5   – Net adjustment items   596.5   –   Adjusted operating cash flow $ 654.4 $ 587.0       Year Ended December 31, 2011 December 31, 2010   Operating cash flow $ 3,374.4 $ 1,416.7 Add: Tax payments related to the 2009 sale of NextRx   –   1,208.0 Net adjustment items   –   1,208.0   Adjusted operating cash flow $ 3,374.4 $ 2,624.7       WellPoint, Inc.Reclassified Consolidated Statement of Income (Unaudited)         WellPoint, Inc. has reclassified certain costs related to its BlueCard program among line items in its 2010 income statement, in order to be comparable with the 2011 financial statement presentation. While this reclassification impacted previously reported administrative fee revenue, benefit expense and SG&A expense, there was no impact on reported net income. The schedule below is provided for reference purposes.       (In millions, except per share data) Three Months Ended December 31, 2010 OriginallyReported Reclassifications As Reclassified Revenues Premiums $ 13,439.9 – $ 13,439.9 Administrative fees 968.6 (25.9 ) 942.7 Other revenue   7.7   –   7.7   Total operating revenue 14,416.2 (25.9 ) 14,390.3   Net investment income 194.5 – 194.5 Net realized gains on investments 47.6 – 47.6   Other-than-temporary impairment losses on investments: Total other-than-temporary impairment losses on investments (17.6 ) – (17.6 ) Portion of other-than-temporary impairment losses recognized in other comprehensive income   7.2   –   7.2   Other-than-temporary impairment losses recognized in income   (10.4 ) –   (10.4 )   Total revenues 14,647.9 (25.9 ) 14,622.0   Expenses Benefit expense 11,355.8 0.8 11,356.6 Selling, general and administrative expense Selling expense 404.1 – 404.1 General and administrative expense   1,963.2   (26.7 )   1,936.5   Total selling, general and administrative expense 2,367.3 (26.7 ) 2,340.6 Interest expense 113.0 – 113.0 Amortization of other intangible assets   59.7   –   59.7   Total expenses 13,895.8 (25.9 ) 13,869.9   Income before income taxes 752.1 – 752.1   Income tax expense   203.3   –   203.3     Net income $ 548.8   – $ 548.8     Net income per diluted share $ 1.40   – $ 1.40     Diluted shares 393.4 – 393.4   Benefit expense as a percentage of premiums 84.5 % – 84.5 % Selling, general and administrative expense as a percentage of total operating revenue 16.4 % (10) bp 16.3 % Income before income tax expense as a percentage of total revenues 5.1 % – 5.1 %       WellPoint, Inc.Reclassified Consolidated Statement of Income (Unaudited)         WellPoint, Inc. has reclassified certain costs related to its BlueCard program among line items in its 2010 income statement, in order to be comparable with the 2011 financial statement presentation. While this reclassification impacted previously reported administrative fee revenue, benefit expense and SG&A expense, there was no impact on reported net income. The schedule below is provided for reference purposes.         (In millions, except per share data) Year Ended December 31, 2010 OriginallyReported Reclassifications As Reclassified Revenues Premiums $ 53,973.6 – $ 53,973.6 Administrative fees 3,833.7 (103.3 ) 3,730.4 Other revenue   36.5   –   36.5   Total operating revenue 57,843.8 (103.3 ) 57,740.5   Net investment income 803.3 – 803.3 Net realized gains on investments 194.1 – 194.1   Other-than-temporary impairment losses on investments: Total other-than-temporary impairment losses on investments (70.8 ) – (70.8 ) Portion of other-than-temporary impairment losses recognized in other comprehensive income   31.4   –   31.4   Other-than-temporary impairment losses recognized in income   (39.4 ) –   (39.4 )   Total revenues 58,801.8 (103.3 ) 58,698.5   Expenses Benefit expense 44,926.9 3.5 44,930.4 Selling, general and administrative expense Selling expense 1,610.3 – 1,610.3 General and administrative expense   7,229.1   (106.8 )   7,122.3   Total selling, general and administrative expense 8,839.4 (106.8 ) 8,732.6 Interest expense 418.9 – 418.9 Amortization of other intangible assets 241.7 – 241.7 Impairment of other intangible assets   21.1   –   21.1   Total expenses 54,448.0 (103.3 ) 54,344.7   Income before income taxes 4,353.8 – 4,353.8   Income tax expense   1,466.7   –   1,466.7     Net income $ 2,887.1   – $ 2,887.1     Net income per diluted share $ 6.94   – $ 6.94     Diluted shares 415.8 – 415.8   Benefit expense as a percentage of premiums 83.2 % – 83.2 % Selling, general and administrative expense as a percentage of total operating revenue 15.3 % (20) bp 15.1 % Income before income tax expense as a percentage of total revenues 7.4 % – 7.4 %       SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995WellPoint and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”), including statements in this press release, in presentations, in filings with the Securities and Exchange Commission, or SEC, in reports to shareholders and in meetings with analysts and investors. The projections referenced in this press release are forward-looking and they are intended to be covered by the safe harbor for “forward-looking statements” provided by PSLRA.Words such as “expect(s)”, “feel(s)”, “believe(s)”, “will”, “may”, “anticipate(s)”, “intend”, “estimate”, “project” and similar expressions are intended to identify forward-looking statements, which generally are not historical in nature. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in our public filings with the SEC; increased government participation in, or regulation or taxation of health benefits and managed care operations, including, but not limited to, the impact of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; trends in health care costs and utilization rates; our ability to secure sufficient premium rates including regulatory approval for and implementation of such rates; our ability to contract with providers consistent with past practice; competitor pricing below market trends of increasing costs; reduced enrollment, as well as a negative change in our health care product mix; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon and funding risks with respect to revenue received from participation therein; a downgrade in our financial strength ratings; litigation and investigations targeted at health benefits companies and our ability to resolve litigation and investigations within estimates; medical malpractice or professional liability claims or other risks related to health care services provided by our subsidiaries; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; non-compliance by any party with the Express Scripts, Inc. pharmacy benefit management services agreement, which could result in financial penalties, our inability to meet customer demands, and sanctions imposed by government entities, including CMS; events that result in negative publicity for us or the health benefits industry; failure to effectively maintain and modernize our information systems and e-business organization and to maintain good relationships with third party vendors for information system resources; events that may negatively affect our license with the Blue Cross and Blue Shield Association; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; intense competition to attract and retain employees; unauthorized disclosure of member sensitive or confidential information; changes in the economic and market conditions, as well as regulations that may negatively affect our investment portfolios and liquidity; possible restrictions in the payment of dividends by our subsidiaries and increases in required minimum levels of capital and the potential negative effect from our substantial amount of outstanding indebtedness; general risks associated with mergers and acquisitions; various laws and our governing documents may prevent or discourage takeovers and business combinations; future public health epidemics and catastrophes; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. Except to the extent otherwise required by federal securities law, we do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in our SEC reports. WellPoint, Inc.Investor RelationsMichael Kleinman, 317-488-6713orMediaKristin Binns, 917-697-7802